Prevention of VTE in Orthopedic Surgery Patients

American Academy of Orthopaedic Surgeons

Guyatt, 2012, Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e185S, 10.1378/chest.11-2289

Hill, 2010, Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance, BMJ, 340, c95, 10.1136/bmj.c95

Kakkar, 2008, Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial, Lancet, 372, 31, 10.1016/S0140-6736(08)60880-6

Eikelboom, 2009, Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials, Circulation, 120, 2006, 10.1161/CIRCULATIONAHA.109.872630

Sevitt, 1959, Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur, Lancet, 2, 981, 10.1016/S0140-6736(59)91464-3

Myhre, 1969, Thrombosis prophylaxis. Dextran or warfarin-sodium? A controlled clinical study [in Norwegian], Nord Med, 82, 1534

Husted, 2010, Low risk of thromboembolic complications after fast-track hip and knee arthroplasty, Acta Orthop, 81, 599, 10.3109/17453674.2010.525196

Galasko, 1976, The value of low dosage heparin for the prophylaxis of thromboembolism in patients with transcervical and intertrochanteric femoral fractures, Acta Orthop Scand, 47, 276, 10.3109/17453677608991991

Sautter, 1983, Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement, JAMA, 250, 2649, 10.1001/jama.1983.03340190051031

Borgstroem, 1965, Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur; a controlled clinical trial using venous phlebography, Acta Chir Scand, 129, 500

Eskeland, 1966, Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures. A controlled clinical trial, Acta Chir Scand, 131, 16

Bjørnarå, 2006, Frequency and timing of clinical venous thromboembolism after major joint surgery, J Bone Joint Surg Br, 88, 386, 10.1302/0301-620X.88B3.17207

Lassen, 2010, Apixaban versus enoxaparin for thromboprophylaxis after hip replacement, N Engl J Med, 363, 2487, 10.1056/NEJMoa1006885

Lassen, 2010, Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial, Lancet, 375, 807, 10.1016/S0140-6736(09)62125-5

Lassen, 2009, Apixaban or enoxaparin for thromboprophylaxis after knee replacement [published correction appears in N Engl J Med. 2009;36(18):1814], N Engl J Med, 361, 594, 10.1056/NEJMoa0810773

Lassen, 2007, The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement, J Thromb Haemost, 5, 2368, 10.1111/j.1538-7836.2007.02764.x

Eriksson, 2006, A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement, Circulation, 114, 2374, 10.1161/CIRCULATIONAHA.106.642074

Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med, 358, 2765, 10.1056/NEJMoa0800374

Turpie, 2005, BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study, J Thromb Haemost, 3, 2479, 10.1111/j.1538-7836.2005.01602.x

Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016

Turpie, 2009, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial, Lancet, 373, 1673, 10.1016/S0140-6736(09)60734-0

Eriksson, 2011, Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial, Thromb Haemost, 105, 721, 10.1160/TH10-10-0679

Eriksson, 2007, Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial, Lancet, 370, 949, 10.1016/S0140-6736(07)61445-7

Ginsberg, 2009, Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery, J Arthroplasty, 24, 1, 10.1016/j.arth.2008.01.132

Eriksson, 2007, Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial, J Thromb Haemost, 5, 2178, 10.1111/j.1538-7836.2007.02748.x

White, 1998, Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty, Arch Intern Med, 158, 1525, 10.1001/archinte.158.14.1525

Eriksson, 2003, Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study, Arch Intern Med, 163, 1337, 10.1001/archinte.163.11.1337

White, 2003, Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures, Thromb Haemost, 90, 446

Pulmonary Embolism Prevention (PEP) Trial Collaborative Group, 2000, Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial, Lancet, 355, 1295, 10.1016/S0140-6736(00)02110-3

Chin, 2009, Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial, J Orthop Surg (Hong Kong), 17, 1, 10.1177/230949900901700101

Fuji, 2008, Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin, J Orthop Sci, 13, 442, 10.1007/s00776-008-1264-0

Lassen, 1988, Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery, Br J Surg, 75, 686, 10.1002/bjs.1800750720

Leclerc, 1992, Prevention of deep vein thrombosis after major knee surgery—a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo, Thromb Haemost, 67, 417, 10.1055/s-0038-1648463

Levine, 1996, Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery, Arch Intern Med, 156, 851, 10.1001/archinte.1996.00440080039005

Samama, 1997, Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery, Br J Anaesth, 78, 660, 10.1093/bja/78.6.660

Tørholm, 1991, Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study, J Bone Joint Surg Br, 73, 434, 10.1302/0301-620X.73B3.1670445

Turpie, 1986, A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery, N Engl J Med, 315, 925, 10.1056/NEJM198610093151503

Yoo, 1997, A prospective randomized study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing elective total hip replacement, Int Orthop, 21, 399, 10.1007/s002640050194

Dahl, 2010, A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty, J Thromb Haemost, 8, 1966, 10.1111/j.1538-7836.2010.03965.x

Pedersen, 2010, Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis, J Bone Joint Surg Am, 92, 2156, 10.2106/JBJS.I.00882

Leizorovicz, 2005, Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study, J Thromb Haemost, 3, 28, 10.1111/j.1538-7836.2004.01094.x

White, 2000, Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty, N Engl J Med, 343, 1758, 10.1056/NEJM200012143432403

Mantilla, 2003, Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty, Anesthesiology, 99, 552, 10.1097/00000542-200309000-00009

Heit, 2000, Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study, Arch Intern Med, 160, 809, 10.1001/archinte.160.6.809

Guyatt, 2012, Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, 53S, 10.1378/chest.11-2288

Lassen, 1991, Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo, Acta Orthop Scand, 62, 33, 10.3109/17453679108993088

Warwick, 1995, Perioperative low-molecular-weight heparin. Is it effective and safe, J Bone Joint Surg Br, 77, 715, 10.1302/0301-620X.77B5.7559695

Jørgensen, 1992, The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study, Clin Orthop Relat Res, 95, 10.1097/00003086-199205000-00015

Sourmelis, 1995, Prevention of deep vein thrombosis with low molecular weight heparin in fractures of the hip [abstract], J Bone Joint Surg Br, 77, 173

O'Donnell, 2003, Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review, Arch Intern Med, 163, 1362, 10.1001/archinte.163.11.1362

Hull, 2001, Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review, Ann Intern Med, 135, 858, 10.7326/0003-4819-135-10-200111200-00006

Eikelboom, 2001, Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials, Lancet, 358, 9, 10.1016/S0140-6736(00)05249-1

Bergqvist, 1996, Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement, N Engl J Med, 335, 696, 10.1056/NEJM199609053351002

Comp, 2001, Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement, J Bone Joint Surg Am, 83-A, 336, 10.2106/00004623-200103000-00004

Dahl, 1997, Prolonged thromboprophylaxis following hip replacement surgery—results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin), Thromb Haemost, 77, 26, 10.1055/s-0038-1655901

Haentjens, 2000, Venous thromboembolism after total hip arthroplasty—review of incidence and prevention during hospitalization and after hospital discharge, Acta Orthop Belg, 66, 1

Hull, 2000, Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison, Arch Intern Med, 160, 2208, 10.1001/archinte.160.14.2208

Lassen, 1998, Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty—the Danish Prolonged Prophylaxis (DaPP) Study, Thromb Res, 89, 281, 10.1016/S0049-3848(98)00018-8

Planes, 1996, Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial, Drugs, 52, 47, 10.2165/00003495-199600527-00009

Morris, 1976, Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur, Lancet, 2, 869, 10.1016/S0140-6736(76)90536-5

Alfaro, 1986, Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine, Thromb Haemost, 56, 53, 10.1055/s-0038-1661602

Dechavanne, 1975, Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients, Haemostasis, 4, 94

Harris, 1977, Aspirin prophylaxis of venous thromboembolism after total hip replacement, N Engl J Med, 297, 1246, 10.1056/NEJM197712082972302

McBride, 1975, Proceedings: failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery, Thromb Diath Haemorrh, 34, 564

McKenna, 1980, Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression, BMJ, 280, 514, 10.1136/bmj.280.6213.514

Encke, 1976, Double-blind study for the prevention of postoperative thrombosis [in German], Chirurg, 47, 670

Morris, 1977, Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen, BMJ, 1, 535, 10.1136/bmj.1.6060.535

Powers, 1989, A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip, Arch Intern Med, 149, 771, 10.1001/archinte.1989.00390040013003

Snook, 1981, Thromboembolism after surgical treatment of hip fractures, Clin Orthop Relat Res, 21

Wood, 1973, Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis, Thromb Diath Haemorrh, 30, 18, 10.1055/s-0038-1649098

Zekert, 1974, Prevention of thromboembolism using acetylsalicylic acid in the surgery of hip-joint proximal fractures [in German], Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed, 77, 97

Hui, 1996, Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement, J Bone Joint Surg Br, 78, 550, 10.1302/0301-620X.78B4.0780550

Dennis, 2009, Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial, Lancet, 373, 1958, 10.1016/S0140-6736(09)60941-7

Muir, 2000, Grosset DG, Lees KR Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke, QJM, 93, 359, 10.1093/qjmed/93.6.359

Hull, 1990, Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement, JAMA, 263, 2313, 10.1001/jama.1990.03440170035032

Wilson, 1992, Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V Impulse System, J Bone Joint Surg Br, 74, 50, 10.1302/0301-620X.74B1.1732265

Bachmann, 1976, Intermittent pneumatic compression of leg and thigh: a new successful method for the prevention of postoperative thrombosis [in German], Schweiz Med Wochenschr, 106, 1819

Fisher, 1995, Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis, J Orthop Trauma, 9, 1, 10.1097/00005131-199502000-00001

Urbankova, 2005, Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients, Thromb Haemost, 94, 1181, 10.1160/TH05-04-0222

Comerota, 1992, Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?, Am J Surg, 164, 265, 10.1016/S0002-9610(05)81083-9

Cornwell, 2002, Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis, Am Surg, 68, 470, 10.1177/000313480206800515

Murakami, 2003, Deep venous thrombosis prophylaxis in trauma: improved compliance with a novel miniaturized pneumatic compression device, J Vasc Surg, 38, 923, 10.1016/S0741-5214(03)00792-4

Fuji, 2008, Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients, Int Orthop, 32, 443, 10.1007/s00264-007-0360-7

Hull, 2000, Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison, Arch Intern Med, 160, 2199, 10.1001/archinte.160.14.2199

Strebel, 2002, Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?, Arch Intern Med, 162, 1451, 10.1001/archinte.162.13.1451

Collins, 1988, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery, N Engl J Med, 318, 1162, 10.1056/NEJM198805053181805

Clagett, 1988, Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis, Ann Surg, 208, 227, 10.1097/00000658-198808000-00016

Colwell, 1999, Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge, J Bone Joint Surg Am, 81, 932, 10.2106/00004623-199907000-00005

Francis, 1997, Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin, J Bone Joint Surg Am, 79, 1365, 10.2106/00004623-199709000-00011

Fitzgerald, 2001, Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin, J Bone Joint Surg Am, 83-A, 900, 10.2106/00004623-200106000-00012

Heit, 1997, Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study, Thromb Haemost, 77, 32, 10.1055/s-0038-1655902

Leclerc, 1996, Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin, Ann Intern Med, 124, 619, 10.7326/0003-4819-124-7-199604010-00001

RD Heparin Arthroplasty Group, 1994, RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty, J Bone Joint Surg Am, 76, 1174, 10.2106/00004623-199408000-00008

Hull, 1993, A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation, N Engl J Med, 329, 1370, 10.1056/NEJM199311043291902

Samama, 2002, Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant, Arch Intern Med, 162, 2191, 10.1001/archinte.162.19.2191

Westrich, 2006, VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty, J Arthroplasty, 21, 139, 10.1016/j.arth.2006.05.017

Graor, 1992, RD heparin (ardeparin sodium) vs. aspirin to prevent deep venous thrombosis after hip or knee replacement surgery [abstract], Chest, 102, 118S

Lassen, 2002, Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison, Lancet, 359, 1715, 10.1016/S0140-6736(02)08652-X

Turpie, 2002, Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial, Lancet, 359, 1721, 10.1016/S0140-6736(02)08648-8

Bauer, 2001, Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery, N Engl J Med, 345, 1305, 10.1056/NEJMoa011099

Eriksson, 2001, Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery, N Engl J Med, 345, 1298, 10.1056/NEJMoa011100

Agnelli, 2005, Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery, Br J Surg, 92, 1212, 10.1002/bjs.5154

Eriksson, 2006, Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement, J Thromb Haemost, 4, 121, 10.1111/j.1538-7836.2005.01657.x

Bailey, 1991, Prospective randomized trial of sequential compression devices vs low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty, J Arthroplasty, 6, S29, 10.1016/S0883-5403(08)80053-8

Francis, 1992, Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement, JAMA, 267, 2911, 10.1001/jama.1992.03480210073035

Paiement, 1987, Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement, J Arthroplasty, 2, 23, 10.1016/S0883-5403(87)80027-X

Kaempffe, 1991, Intermittent pneumatic compression versus coumadin. Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty, Clin Orthop Relat Res, 89

Pitto, 2004, Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial, J Bone Joint Surg Br, 86, 639, 10.1302/0301-620X.86B5.14763

Stone, 1996, A comparison of intermittent calf compression and enoxaparin for thromboprophylaxis in total hip replacement. A pilot study, Int Orthop, 20, 367, 10.1007/s002640050099

Warwick, 1998, Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial, J Bone Joint Surg Am, 80, 1158, 10.2106/00004623-199808000-00009

Blanchard, 1999, Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system, J Bone Joint Surg Br, 81, 654, 10.1302/0301-620X.81B4.9464

Colwell, 2010, Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin, J Bone Joint Surg Am, 92, 527, 10.2106/JBJS.I.00047

Gelfer, 2006, Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin, J Arthroplasty, 21, 206, 10.1016/j.arth.2005.04.031

Kakkos, 2008, Nicolaides AN, Stansby GP, Reddy DJ Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients, Cochrane Database Syst Rev, CD005258

Borow, 1983, Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities, Am Surg, 49, 599

Bradley, 1993, The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty, J Arthroplasty, 8, 57, 10.1016/S0883-5403(06)80108-7

Eisele, 2007, Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis, J Bone Joint Surg Am, 89, 1050, 10.2106/JBJS.E.00434

Silbersack, 2004, Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression, J Bone Joint Surg Br, 86, 809, 10.1302/0301-620X.86B6.13958

Edwards, 2008, Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty, J Arthroplasty, 23, 1122, 10.1016/j.arth.2007.11.006

Wilke, 2010, Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: a systematic review, Expert Rev Pharmacoecon Outcomes Res, 10, 691, 10.1586/erp.10.77

Rajasekhar, 2011, Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines, J Thromb Thrombolysis, 32, 40, 10.1007/s11239-010-0544-7

Bass, 2010, Inferior vena cava filter placement in orthopedic surgery, Am J Orthop, 39, 435

Robinson, 1997, Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial, Ann Intern Med, 127, 439, 10.7326/0003-4819-127-6-199709150-00004

Schmidt, 2003, Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial, Thromb Haemost, 90, 949

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 381S, 10.1378/chest.08-0656

Testroote, 2008, Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization, Cochrane Database Syst Rev, CD006681

Selby, 2007, Clinically-Important Venous ThromboEmbolism (CIVTE) following isolated leg fractures distal to the knee: epidemiology and preventions: the D-KAF (Dalteparin in Knee to Ankle Fracture) trial [abstract], J Thromb Haemost, 5

Ramos, 2008, Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy, Cochrane Database Syst Rev, CD005259

Canata G, Chiey A. Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine; 2003; Poster 71-2003

Michot, 2002, Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low-molecular weight heparin, Arthroscopy, 18, 257, 10.1053/jars.2002.30013

Roth, 1995, Prophylaxis of deepvein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefürten arthroskopischen Meniskusoperationen], Orthopädische Praxis, 5, 345

Wirth, 2001, Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial, Arthroscopy, 17, 393, 10.1053/jars.2001.21247

Camporese, 2008, Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial, Ann Intern Med, 149, 73, 10.7326/0003-4819-149-2-200807150-00003

Dahl, 2008, International Surgical Thrombosis Forum. Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use, Int Angiol, 27, 60